Updates are available Correction dated 2022-04-21
Click to view Correction: https://doi.org/10.1038/s41467-022-30054-8
-
Authors
Elleman, Anna V.
Devienne, Gabrielle https://orcid.org/0000-0002-2204-8043
Makinson, Christopher D. https://orcid.org/0000-0002-1427-8148
Haynes, Allison L.
Huguenard, John R. https://orcid.org/0000-0002-6950-1191
Du Bois, J. https://orcid.org/0000-0001-7847-1548
- License Information
-
More Information
Article History
Received: 3 December 2020
Accepted: 9 June 2021
First Online: 7 July 2021
Change Date: 21 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-30054-8
Competing interests
: J.D. is a cofounder and holds equity shares in SiteOne Therapeutics, Inc., a startup company interested in developing subtype-selective Na<sub>V</sub> modulators. The remaining authors declare no competing interests.
